Codexis (CDXS) Operating Expenses (2010 - 2026)
Codexis' (CDXS) quarterly Operating Expenses came in at $23.3 million in Q1 2026, down 16.9% year-on-year from $28.0 million in Q1 2025, and down 17.86% quarter-over-quarter from $28.4 million in Q4 2025.
Codexis (CDXS) Operating Expenses (2010 - 2026) Analysis & Trends
Codexis' Operating Expenses history runs 17 years deep, the most recent figure standing at $23.3 million for Q1 2026.
- On a quarterly basis, Operating Expenses fell 16.9% year-over-year to $23.3 million in Q1 2026; TTM through Mar 2026 was $107.4 million, a 8.16% decrease from a year earlier, with the FY2025 full-year figure at $112.1 million, down 4.87% from the prior year.
- Operating Expenses retreated to $23.3 million in Q1 2026 per CDXS's latest filing, from $28.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $45.1 million in Q3 2022 and bottomed at $23.3 million in Q1 2026.
- The 5-year median for Operating Expenses is $29.4 million (2024), against an average of $33.2 million.
- Across the five-year window, Operating Expenses surged 60.83% in 2022 and tumbled 39.76% in 2023, its largest moves.
- Year by year, Operating Expenses stood at $43.6 million in 2022, then tumbled by 39.76% to $26.3 million in 2023, then gained by 9.59% to $28.8 million in 2024, then dropped by 1.55% to $28.4 million in 2025, then slipped by 17.86% to $23.3 million in 2026.
- Per Business Quant, the three latest CDXS Operating Expenses figures stand at $23.3 million (Q1 2026), $28.4 million (Q4 2025), and $27.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | 23.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.29 Mn |
| Dec 31, 2025 | 28.36 Mn |
| Sep 30, 2025 | 27.55 Mn |
| Jun 30, 2025 | 28.19 Mn |
| Mar 31, 2025 | 28.03 Mn |
| Dec 31, 2024 | 28.80 Mn |
| Sep 30, 2024 | 29.39 Mn |
| Jun 30, 2024 | 30.71 Mn |
| Mar 31, 2024 | 28.96 Mn |
| Dec 31, 2023 | 26.28 Mn |
| Sep 30, 2023 | 41.34 Mn |
| Jun 30, 2023 | 33.95 Mn |
| Mar 31, 2023 | 36.65 Mn |
| Dec 31, 2022 | 43.63 Mn |
| Sep 30, 2022 | 45.11 Mn |
| Jun 30, 2022 | 41.02 Mn |
| Mar 31, 2022 | 43.73 Mn |
| Dec 31, 2021 | 34.89 Mn |
| Sep 30, 2021 | 35.44 Mn |
| Jun 30, 2021 | 29.94 Mn |